DexCom, Inc. (DXCM)
NASDAQ
Real-time Data
01:30 PM
Day's Range
91.0352 wk Range
54.11Overview - DXCM - DexCom, Inc.
Key Statistics
Valuation
Enterprise Value
34.29B
P/E (Trailing)
‪36.52‬
P/E (Forward)
‪29.57‬
PEG Ratio
‪0.88‬
Price / Sales (TTM)
‪7.01‬
Price / Book
‪13.30‬
EV / EBITDA
‪24.44‬
Profitability
Gross Margin
‪63.43%‬
Profit Margin
‪20.11%‬
Operating Margin
‪24.32%‬
Return on Assets
‪10.33%‬
Return on Equity
‪38.49%‬
Ownership
Shares Outstanding
377.40M
Float
375.95M
Short % of Shares Outstanding
‪5.37%‬
Held by Insiders
‪0.27%‬
Held by Institutions
‪106.34%‬
Price stats
Beta
‪1.41‬
50-Day Avg
‪77.63‬
200-Day Avg
‪69.32‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
28 analysts
Average price target
‪$ 94.12‬Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - DXCM - DexCom, Inc.
Peers - DXCM - DexCom, Inc.
Peer Comparison
Compared with companies in Medical Devices listed on NASDAQ.
Profile Summary - DXCM - DexCom, Inc.
About
DexCom, Inc. is a leading medical technology company specializing in continuous glucose monitoring (CGM) systems for diabetes management. Its primary products deliver real-time glucose readings through small, wearable sensors that provide accurate, personalized data to users, simplifying daily monitoring and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
